KMT2A and Ewing sarcoma: In addition, we have tested if exposure of Ewing sarcoma cells to MI-503, a recently developed inhibitor of the MLL-menin protein-protein interaction [33, 34], impacts on tumorigenicity or posterior HOXD gene expression.